40,000 doses of opioid-blocker naloxone, the ‘Lazarus drug’

As the U. S. government and health care providers grapple with the exploding rates of opioid abuse across the country, the Clinton foundation has expanded its partnership with Adapt Pharma, maker of Narcan nasal spray, by donating 40,000 doses of the opioid overdose reversal drug to colleges and universities all over the United States.
 
Narcan, a brand of the generic drug naloxone, is used for the emergency cure of known or suspected opioid overdose.
 
“We know that most overdose deaths don’t happen in hospitals, which is why we’re working with Adapt Pharma, the yank school Nurses Association, and a number of other partners to make FDA-approved naloxone Narcan nasal spray readily available in high schools, colleges and universities, and other community centers where folks already are,” stated Alex Chan, director of national Health for the Clinton Health topics Initiative , an initiative of the Clinton Foundation. “President Bill Clinton has spoken about younger men he knew who had suffered from accidental drug overdoses, and it prompted the Clinton Foundation to look closely at the issue of prescription drug misuse, and discover what we might be equipped to do,” Chan added. Hillary Clinton also expressed her passion for combating the crisis. throughout her presidential campaign final year, she laid out a detailed plan for tackling the epidemic, vowing to put $10 billion over 10 years towards a coalition she referred to as the “Initiative to Combat America’s lethal Epidemic of Drug and Alcohol Addiction. ” It was an exhaustive plan in which, among many other details, Clinton promised to require better coaching and tracking for opioid prescriptions, improve barriers to care to create more preventive efforts and medication programs, reform the criminal justice system to stay away from setting drug users in prison, and offer simpler access to naloxone for first responders. one of the universities receiving naloxone from the new partnership are 53 member colleges within the association of Independent Colleges and Universities of Ohio. Ohio is a state with one of the highest rates of death as a consequence of prescription and illicit overdoses in the country. “This initiative further equips colleges and universities to take a proactive approach to the growing opioid epidemic,” Robert Helmer, president of Ohio’s Baldwin Wallace University, said in a statement. Patented in 1961 and approved by the FDA in 1971, naloxone isn’t addictive and is most commonly administered intravenously, even though a more user-friendly nasal spray is now available.

Back to Top